This study is looking at the Investigation of Optical Coherence Tomography Angiography (OCTA) as a non-invasive technique to detect early retinal microvascular dysfunction in children with Diabetes Mellitus.
Primary outcomes:
To see if there are changes that can be seen in the eye using OCT-A in diabetic children compared to non-diabetic children earlier than when they would normally be detected using the current standard of care.
To compare these early changes in the eye with biomarkers seen in the kidney for diabetic children.
- This study is looking at the following cohorts:
Diabetic Participants – entering the longitudinal study
Children aged 10-18 diagnosed with diabetes Type 1 or 2 - Diabetic patients entering the observational cohort
Children aged 10-18 diagnosed with diabetes Type 1 or 2 and a grading of “no retinopathy” per ETDRS classification - Healthy Participants entering the observational cohort
Aged 10-18
Principal Investigator: Chandra Balaratnasingam
Australian New Zealand Clinical Trials Registry (ANZCTR) Number: ACTRN12624000887572
You may visit ANZCTR for more information regarding the CB-2022-01 Paediatric DR Study.
To enquire further about this study, please contact Lions Vision Trials on (08) 9381 0755, or email lionsvisiontrials@lei.org.au
